Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Pharmacological management of binge eating disorder: current and emerging treatment options

Authors McElroy S, Guerdjikova AI, Mori N, O’Melia A

Received 2 March 2012

Accepted for publication 24 March 2012

Published 8 May 2012 Volume 2012:8 Pages 219—241

DOI https://doi.org/10.2147/TCRM.S25574

Review by Single-blind

Peer reviewer comments 3


Susan L McElroy, Anna I Guerdjikova, Nicole Mori, Anne M O'Melia

Lindner Center of HOPE, Mason, and Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Abstract: Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors. In this paper, we provide a brief overview of BED and review the rationales and data supporting the effectiveness of specific medications or medication classes in treating patients with BED. We conclude by summarizing these data, discussing the role of pharmacotherapy in the BED treatment armamentarium, and suggesting future areas for research.

Keywords: binge eating disorder, pharmacotherapy, medication management

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]